Philippe Auclair Pharma Dr, PhD, FRAPS

Philippe joined Abbott in 1994. He is currently responsible for Regulatory Strategy and Advocacy. He represents European Industry in various European Commission expert groups and served until the end of 2012 as secretary of the Global Harmonization Task Force Study group 2 dealing with adverse events reporting. He actively participates as a trainer in programs organized by Regulatory Authorities in various geographies, such as Europe, Colombia, Brazil, China, India, Mexico, United States and serves since 2015 as an advisor to the Asian Harmonization Working Party Technical Committee.

He is Chairman of the Post Market Surveillance, and the Notified Body Working Groups of the European medical device manufacturers’ trade association Medtech Europe. He is a member of the REC and of the board nominating committee of the Regulatory Affairs Professional Society (RAPS). Philippe received the “Global Leadership Award” from RAPS in 2010, has been elected “RAPS Fellow” in 2012. Philippe is also the proud recipient of an FDA CDRH Director’s “Special Citation” for his work at GHTF.